The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology
NCT01838564 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104
Last updated 2013-04-29
Summary
Over 50% of children dying from cancer still suffer from symptoms that could be effectively alleviated. The purpose of the Pediatric Quality of Life and Evaluation of Symptoms Technology (PediQUEST) Study was to evaluate whether providing feedback to families and providers about how the child is feeling improved child distress and quality of life (QoL) in children with advanced cancer.
PediQUEST is a computerized survey that asks the child and/or parents how the child has been feeling, i.e. whether the child had any physical or emotional symptoms, as well as how other aspects of life, such as school and friends, are going. After the survey is complete a report that summarizes patient/parent answers is printed. When a child reports moderate to high distress from any symptom an email is automatically sent to the primary providers (oncologist, nurse, and psycho-social clinician as well as the pain and palliative care services) alerting them about the child's distress.
In this study we evaluated whether using PediQUEST and providing printed reports to parents and providers reduced distress and improved quality of life in children with advanced cancer. In addition, we wanted to understand whether it was feasible to carry out a randomized controlled trial in children with advanced cancer. Finally, the data collected, will be used to describe the natural history of symptoms and quality of life as reported by the children.
Children enrolled in the study (or their parents) were asked to complete a PediQUEST survey at most once a week. A random half of the children received the feedback intervention, i.e. patients, parents, and providers received printed reports (and emails if the child was in distress). The other half only completed the PediQUEST surveys and did not receive reports. We analyzed data collected over 20 weeks of follow-up to see whether receiving PediQUEST reports had any effect on child distress and quality of life.
Conditions
- Pediatric Neoplasm
- Quality of Life
- Outcome Assessment
- Palliative Care
Interventions
- OTHER
-
Routine Data collection
Patients assigned to the control arm answered PediQUEST (PQ) surveys at most once a week and at least once a month. PQ-surveys were administered through a tablet computer if patient was at the clinic or ward or over the phone if patient was primarily at home. PQ-survey had 9 age- and respondent- adapted versions. Control arm participants reported their satisfaction with the PediQUEST technology twice 4th and 8th PediQUEST administration. These surveys were embedded in PediQUEST.
- OTHER
-
Feedback of patient-reported outcomes
Patients, parents and primary providers received printed reports summarizing patient/parent reported outcomes for last five visits. When child reported moderate-severe distress an email was automatically sent to primary providers (oncologist, nurses and psychosocial clinicians), as well as to the pain and palliative care services.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH - lead OTHER
Principal Investigators
-
Joanne Wolfe, MD · Dana-Farber Cancer Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-11-30
- Primary Completion
- 2009-12-31
- Completion
- 2010-06-30
Countries
- United States
Study Locations
More Related Trials
-
Validation Study of Pediatric Patient-Reported Outcomes
NCT03229837 ·Status: COMPLETED
-
PCRC-Supported Legacy Intervention in Pediatric Palliative Care
NCT04059393 ·Status: COMPLETED ·Phase: NA
-
Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
NCT00091091 ·Status: COMPLETED
-
Irinotecan in Treating Children With Refractory or Progressive Solid Tumors
NCT00016861 ·Status: COMPLETED ·Phase: PHASE1
-
Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors
NCT06926751 ·Status: RECRUITING ·Phase: PHASE2
-
PediCARE Health Equity Intervention in High-Risk Neuroblastoma
NCT06335745 ·Status: WITHDRAWN ·Phase: NA
-
Radiation Therapy and the Natural History of Childhood Cancers
NCT00064883 ·Status: COMPLETED
-
Three Times Weekly Symptom Screening for Children With Cancer
NCT04275102 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Fenretinide in Treating Children With Solid Tumors
NCT00003191 ·Status: COMPLETED ·Phase: PHASE1
-
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
NCT00002485 ·Status: COMPLETED
-
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
NCT03178617 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of @neWorld: A Virtual Community for Children With Cancer
NCT00070421 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial
NCT00890435 ·Status: COMPLETED
-
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
NCT02847130 ·Status: COMPLETED
-
Home Chemotherapy Intervention for Children With Cancer - a Feasibility Study
NCT05372536 ·Status: COMPLETED ·Phase: NA
-
Infections in Pediatric Cancer Patients
NCT00930267 ·Status: UNKNOWN
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
NCT00017368 ·Status: COMPLETED ·Phase: PHASE2
-
The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network
NCT05454618 ·Status: RECRUITING
-
Symptom Clusters in Children With Leukemia
NCT01708421 ·Status: COMPLETED
-
Evaluation of Proton Therapy in Pediatric Cancer Patients
NCT03223766 ·Status: ACTIVE_NOT_RECRUITING
-
SPARK Symptom Screening and Feedback to Providers
NCT03593525 ·Status: COMPLETED ·Phase: NA
-
Video Inspired Discussions About Ethical Outcomes in Pediatrics
NCT06786104 ·Status: RECRUITING ·Phase: NA
-
Clinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy
NCT06857292 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Pemetrexed in Children With Recurrent Cancer
NCT00520936 ·Status: COMPLETED ·Phase: PHASE2
-
Therapy for Children With Neuroblastoma
NCT00135135 ·Status: COMPLETED ·Phase: PHASE2